Highly Persistent and Effective Prime/Boost Regimens Against Tuberculosis That Use a Multivalent Modified Vaccine Virus Ankara-Based Tuberculosis Vaccine With Interleukin-15 as a Molecular Adjuvant

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00006-10

Related search